Primary diffuse large B-cell lymphoma of the dura with skull and scalp involvement: A case report and brief review of the literature

被引:10
作者
Lv, Zhong-Wen [1 ]
Cheng, Kai-Liang [1 ]
Tian, Hong-Ji [2 ]
Han, Xue-Mei [2 ]
机构
[1] Jilin Univ, China Japan Union Hosp, Dept Radiol, Changchun 130031, Jilin, Peoples R China
[2] Jilin Univ, China Japan Union Hosp, Dept Neurol, 2 Xian Tai Ave, Changchun 130031, Jilin, Peoples R China
关键词
magnetic resonance imaging; dura lymphoma; diffuse large B-cell lymphoma; chemotherapy; CENTRAL-NERVOUS-SYSTEM; NON-HODGKINS-LYMPHOMA; MALIGNANT-LYMPHOMA; MIMICKING; TISSUE; CHEMOTHERAPY; RADIOTHERAPY;
D O I
10.3892/ol.2016.4455
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Primary dural lymphoma (PDL) refers to a lymphoma with epidural or subdural involvement and is a rare subtype of primary central nervous system lymphoma. Diffuse large B-cell lymphoma (DLBCL) presenting as PDL is extremely rare. The present study reports a case of PDL with skull and scalp involvement in a 56-year-old man. Magnetic resonance imaging (MRI) revealed that the tumor was located under the right parietal inner plate and was attached to the dura mater. Following contrast-enhanced MRI, markedly enhanced tumor signals were observed, and mild homogeneous enhancement was observed in the diploe and soft tissues under the scalp, near the parietal bone. Under general anesthesia, the patient underwent craniotomy and tumor resection. The postoperative pathological diagnosis was DLBCL. Tumors were additionally identified inside the skull and subcutaneous tissues. The patient was administered chemotherapy postoperatively, and the prognosis subsequent to the 4-year follow-up was favorable. Primary malignant lymphoma should be considered in the differential diagnosis of scalp masses and meningeal lesions. Early diagnosis and individualized treatment is closely associated with a favorable outcome.
引用
收藏
页码:3583 / 3588
页数:6
相关论文
共 33 条
[1]   Treatment for primary CNS lymphoma: The next step [J].
Abrey, LE ;
Yahalom, J ;
DeAngelis, LM .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (17) :3144-3150
[2]   Prognostic value of complete remission status at end-of-treatment FDG-PET in R-CHOP-treated diffuse large B-cell lymphoma: systematic review and meta-analysis [J].
Adams, Hugo J. A. ;
Nievelstein, Rutger A. J. ;
Kwee, Thomas C. .
BRITISH JOURNAL OF HAEMATOLOGY, 2015, 170 (02) :185-191
[3]  
Benouaich A, 2003, REV NEUROL-FRANCE, V159, P652
[4]  
Brito ABC, 2014, INT J CLIN EXP MED, V7, P456
[5]   Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group study 93-10 [J].
DeAngelis, LM ;
Seiferheld, W ;
Schold, SC ;
Fisher, B ;
Schultz, CJ .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (24) :4643-4648
[6]   Medical progress: Brain tumors [J].
DeAngelis, LM .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (02) :114-123
[7]  
ERVIN T, 1980, CANCER, V45, P1556, DOI 10.1002/1097-0142(19800401)45:7<1556::AID-CNCR2820450707>3.0.CO
[8]  
2-B
[9]   Summary statement on primary central nervous system lymphomas from the Eighth International Conference on Malignant Lymphoma, Lugano, Switzerland, June 12 to 15, 2002 [J].
Ferreri, AJM ;
Abrey, LE ;
Blay, JY ;
Borisch, B ;
Hochman, J ;
Neuwelt, EA ;
Yahalom, J ;
Zucca, E ;
Cavalli, F ;
Armitage, J ;
Batchelor, T .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (12) :2407-2414
[10]  
Freudenstein D, 2000, CLIN NEUROPATHOL, V19, P34